000823868 001__ 823868
000823868 005__ 20210129224857.0
000823868 0247_ $$2doi$$a10.1021/acs.jpcb.6b00059
000823868 0247_ $$2ISSN$$a1089-5647
000823868 0247_ $$2ISSN$$a1520-5207
000823868 0247_ $$2ISSN$$a1520-6106
000823868 0247_ $$2WOS$$aWOS:000373416700001
000823868 0247_ $$2altmetric$$aaltmetric:6195462
000823868 0247_ $$2pmid$$apmid:26965454
000823868 037__ $$aFZJ-2016-06508
000823868 082__ $$a530
000823868 1001_ $$0P:(DE-HGF)0$$aCarballo-Pacheco, Martín$$b0
000823868 245__ $$aAdvances in the Simulation of Protein Aggregation at the Atomistic Scale
000823868 260__ $$aWashington, DC$$bSoc.$$c2016
000823868 3367_ $$2DRIVER$$aarticle
000823868 3367_ $$2DataCite$$aOutput Types/Journal article
000823868 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1479799812_4738
000823868 3367_ $$2BibTeX$$aARTICLE
000823868 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000823868 3367_ $$00$$2EndNote$$aJournal Article
000823868 520__ $$aProtein aggregation into highly structured amyloid fibrils is associated with various diseases including Alzheimer’s disease, Parkinson’s disease, and type II diabetes. Amyloids can also have normal biological functions and, in the future, could be used as the basis for novel nanoscale materials. However, a full understanding of the physicochemical forces that drive protein aggregation is still lacking. Such understanding is crucial for the development of drugs that can effectively inhibit aberrant amyloid aggregation and for the directed design of functional amyloids. Atomistic simulations can help understand protein aggregation. In particular, atomistic simulations can be used to study the initial formation of toxic oligomers which are hard to characterize experimentally and to understand the difference in aggregation behavior between different amyloidogenic peptides. Here, we review the latest atomistic simulations of protein aggregation, concentrating on amyloidogenic protein fragments, and provide an outlook for the future in this field.
000823868 536__ $$0G:(DE-HGF)POF3-553$$a553 - Physical Basis of Diseases (POF3-553)$$cPOF3-553$$fPOF III$$x0
000823868 588__ $$aDataset connected to CrossRef
000823868 7001_ $$0P:(DE-Juel1)132024$$aStrodel, Birgit$$b1$$eCorresponding author$$ufzj
000823868 773__ $$0PERI:(DE-600)2006039-7$$a10.1021/acs.jpcb.6b00059$$gVol. 120, no. 12, p. 2991 - 2999$$n12$$p2991 - 2999$$tThe @journal of physical chemistry <Washington, DC> / B$$v120$$x1520-5207$$y2016
000823868 8564_ $$uhttps://juser.fz-juelich.de/record/823868/files/Advances%20in%20the%20Simulation%20of%20Protein%20Aggregation%20at%20the%20Atomistic%20Scale_2016.pdf$$yRestricted
000823868 8564_ $$uhttps://juser.fz-juelich.de/record/823868/files/Advances%20in%20the%20Simulation%20of%20Protein%20Aggregation%20at%20the%20Atomistic%20Scale_2016.gif?subformat=icon$$xicon$$yRestricted
000823868 8564_ $$uhttps://juser.fz-juelich.de/record/823868/files/Advances%20in%20the%20Simulation%20of%20Protein%20Aggregation%20at%20the%20Atomistic%20Scale_2016.jpg?subformat=icon-1440$$xicon-1440$$yRestricted
000823868 8564_ $$uhttps://juser.fz-juelich.de/record/823868/files/Advances%20in%20the%20Simulation%20of%20Protein%20Aggregation%20at%20the%20Atomistic%20Scale_2016.jpg?subformat=icon-180$$xicon-180$$yRestricted
000823868 8564_ $$uhttps://juser.fz-juelich.de/record/823868/files/Advances%20in%20the%20Simulation%20of%20Protein%20Aggregation%20at%20the%20Atomistic%20Scale_2016.jpg?subformat=icon-640$$xicon-640$$yRestricted
000823868 8564_ $$uhttps://juser.fz-juelich.de/record/823868/files/Advances%20in%20the%20Simulation%20of%20Protein%20Aggregation%20at%20the%20Atomistic%20Scale_2016.pdf?subformat=pdfa$$xpdfa$$yRestricted
000823868 909CO $$ooai:juser.fz-juelich.de:823868$$pVDB
000823868 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132024$$aForschungszentrum Jülich$$b1$$kFZJ
000823868 9131_ $$0G:(DE-HGF)POF3-553$$1G:(DE-HGF)POF3-550$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lBioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences$$vPhysical Basis of Diseases$$x0
000823868 9141_ $$y2016
000823868 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000823868 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000823868 915__ $$0StatID:(DE-HGF)1150$$2StatID$$aDBCoverage$$bCurrent Contents - Physical, Chemical and Earth Sciences
000823868 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000823868 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000823868 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000823868 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000823868 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000823868 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ PHYS CHEM B : 2015
000823868 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000823868 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000823868 915__ $$0StatID:(DE-HGF)0550$$2StatID$$aNo Authors Fulltext
000823868 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000823868 920__ $$lyes
000823868 9201_ $$0I:(DE-Juel1)ICS-6-20110106$$kICS-6$$lStrukturbiochemie $$x0
000823868 980__ $$ajournal
000823868 980__ $$aVDB
000823868 980__ $$aUNRESTRICTED
000823868 980__ $$aI:(DE-Juel1)ICS-6-20110106
000823868 981__ $$aI:(DE-Juel1)IBI-7-20200312